Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1972 Sep 16;3(5828):669–672. doi: 10.1136/bmj.3.5828.669

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

G M Besser, Lynne Parke, C R W Edwards, Isabel A Forsyth, A S McNeilly
PMCID: PMC1786102  PMID: 4675488

Abstract

In five patients with inappropriate lactation and amenorrhoea or impotence brom-ergocryptine was found to suppress the lactation and to diminish the raised plasma prolactin levels. The responses to treatment suggest that there may be an inverse relationship between prolactin secretion and gonadotrophin secretion in man.

Full text

PDF
669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C., Marshall J. C., Young J. L., Fraser T. R. Stimulation tests of pituitary-Leydig cell function in normal male subjects and hypogonadal men. Clin Endocrinol (Oxf) 1972 Apr;1(2):127–140. doi: 10.1111/j.1365-2265.1972.tb00384.x. [DOI] [PubMed] [Google Scholar]
  2. Ben-David M., Danon A., Sulman F. G. Evidence of antagonism between prolactin and gonadotrophin secretion: effect of methalibure on perphenazine-induced prolactin secretion inovariectomized rats. J Endocrinol. 1971 Dec;51(4):719–725. doi: 10.1677/joe.0.0510719. [DOI] [PubMed] [Google Scholar]
  3. Besser G. M., Edwards C. R. Galactorrhoea. Br Med J. 1972 Apr 29;2(5808):280–282. doi: 10.1136/bmj.2.5808.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Billeter E., Flückinger E. Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154). Experientia. 1971 Apr 15;27(4):464–465. doi: 10.1007/BF02137315. [DOI] [PubMed] [Google Scholar]
  5. Flückiger E., Wagner H. R. 2-Br-alpha-Ergokryptin: Beeinflussung von Fertilität und Laktation bei der Ratte. Experientia. 1968 Nov 15;24(11):1130–1131. doi: 10.1007/BF02147804. [DOI] [PubMed] [Google Scholar]
  6. Forsyth I. A., Besser G. M., Edwards C. R., Francis L., Myres R. P. Plasma prolactin activity in inappropriate lactation. Br Med J. 1971 Jul 24;3(5768):225–227. doi: 10.1136/bmj.3.5768.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forsyth I. A., Myres R. P. Human prolactin. Evidence obtained by the bioassay of human plasma. J Endocrinol. 1971 Sep;51(1):157–168. doi: 10.1677/joe.0.0510157. [DOI] [PubMed] [Google Scholar]
  8. Friesen H., Guyda H., Hwang P., Tyson J. E., Barbeau A. Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest. 1972 Mar;51(3):706–709. doi: 10.1172/JCI106859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hall R., Ormston B. J., Besser G. M., Cryer R. J. The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet. 1972 Apr 8;1(7754):759–763. doi: 10.1016/s0140-6736(72)90518-1. [DOI] [PubMed] [Google Scholar]
  10. Hwang P., Guyda H., Friesen H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1902–1906. doi: 10.1073/pnas.68.8.1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hökfelt T., Fuxe K. Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology. 1972;9(2):100–122. doi: 10.1159/000122042. [DOI] [PubMed] [Google Scholar]
  12. Kamberi I. A., Mical R. S., Porter J. C. Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology. 1971 Jun;88(6):1288–1293. doi: 10.1210/endo-88-6-1288. [DOI] [PubMed] [Google Scholar]
  13. Kamberi I. A., Mical R. S., Porter J. C. Pituitary portal vessel infusion of hypothalamic extract and release of LH, FSH and prolactin. Endocrinology. 1971 Jun;88(6):1294–1299. doi: 10.1210/endo-88-6-1294. [DOI] [PubMed] [Google Scholar]
  14. Kleinberg D. L., Frantz A. G. Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest. 1971 Aug;50(8):1557–1568. doi: 10.1172/JCI106643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lutterbeck P. M., Pryor J. S., Varga L., Wenner R. Treatment of non-puerperal galactorrhoea with an ergot alkaloid. Br Med J. 1971 Jul 24;3(5768):228–229. doi: 10.1136/bmj.3.5768.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Malarkey W. B., Jacobs L. S., Daughaday W. H. Levodopa suppression of prolactin in nonpuerperal galactorrhea. N Engl J Med. 1971 Nov 18;285(21):1160–1163. doi: 10.1056/NEJM197111182852102. [DOI] [PubMed] [Google Scholar]
  17. Ormston B. J., Cryer R. J., Garry R., Besser G. M., Hall R. Thyrotrophin-releasing hormone as a thyroid-function test. Lancet. 1971 Jul 3;2(7714):10–14. doi: 10.1016/s0140-6736(71)90005-5. [DOI] [PubMed] [Google Scholar]
  18. Pasteels J. L., Danguy A., Frérotte M., Ectors F. Inhibition de la sécrétion de prolactine par l'ergocornine et la 2-Br-alpha-ergocryptine: action directe sur l'hypophyse en culture. Ann Endocrinol (Paris) 1971 Jan-Feb;32(1):188–192. [PubMed] [Google Scholar]
  19. Turkington R. W. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa. J Clin Endocrinol Metab. 1972 Feb;34(2):306–311. doi: 10.1210/jcem-34-2-306. [DOI] [PubMed] [Google Scholar]
  20. Varga L., Lutterbeck P. M., Pryor J. S., Wenner R., Erb H. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study. Br Med J. 1972 Jun 24;2(5816):743–744. doi: 10.1136/bmj.2.5816.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yanai R., Nagasawa H. Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice. Experientia. 1970 Jun 15;26(6):649–650. doi: 10.1007/BF01898742. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES